EDIT vs PSX · rev $32.3M vs P/E 17, rev $143.15B
Editas Medicine Inc (EDIT) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
EDIT currently screens at market cap $375.2M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the EDIT and PSX stock pages for the full models.
Not investment advice.